NSE: VINEETLAB · PHARMACEUTICALS

Vineet Laboratories Limited Share Price & Company Info

₹37.52-0.69%

End-of-day price, · Educational content, not investment advice

52W low ₹27.9652W high ₹43.50
Market cap
₹72.83 Cras reported by NSE
52-week high
₹43.5027-APR-2026
52-week low
₹27.9609-MAR-2026
P/E (NSE)
18.28
Face value
₹10.00
Shares issued
1,92,06,266
Volume
70,373₹0.26 Cr traded
Delivery
61.18%of traded quantity
Price band
10%₹33.99 – ₹41.53 on 2026-11-02
Annual volatility
53.11%NSE, from daily returns
Series
EQrolling settlement
BSE group
Bscrip code 543298
ISIN
INE505Y01010
Listed on NSE
15-Jun-2021

About Vineet Laboratories Limited

Vineet Laboratories Limited is listed on the National Stock Exchange of India under the symbol VINEETLAB in the EQ series. NSE classifies it under the basic industry Pharmaceuticals, part of the Healthcare sector. Its shares were listed on NSE on 15-Jun-2021. Each share has a face value of ₹10.00.

In the end-of-day data for 16 November 2026 the stock closed at ₹37.52, down 0.69% on the day. NSE puts the company's market capitalisation at about ₹72.83 crore, which puts it among the smallest listed companies in India. Over the past 52 weeks it has traded between ₹27.96 and ₹43.50, so the last price is 34.2% above the low and 13.7% below the high.

70,373 shares changed hands that day, and 61.18% of them were taken as delivery rather than squared off intraday. A high delivery share means most of the day's buyers chose to hold the shares; a low one usually means the volume was mostly short-term trading.

EQ is the normal equity series: shares settle on the usual T+1 cycle and intraday trading is allowed.

NSE currently lists a regulatory note for this stock: “Less than 100 unique PAN traded in prev. 30 days”. Notes like these come from the exchange's surveillance and disclosure checks and can mean higher margins, trade-for-trade settlement or limits on trading. Check the NSE quote page for the current position before trading.

NSE puts the stock's annualised volatility at 53.11%. That is well above the level of large, established companies, so double-digit swings within a month are common.

Because the share trades below ₹50, it also appears in our list of penny stocks under ₹50, which explains the extra risks that come with low-priced shares.

Vineet Laboratories Limited quarterly results

In the quarter ended June 2026 (un-audited), Vineet Laboratories Limited reported total income of ₹10.50 crore and a net profit of ₹1.51 crore, or ₹0.00 per share. That is a net margin of 14.4% on income.

Compared with the previous quarter (March 2026), income fell 44.5%.

Vineet Laboratories Limited was profitable in 4 of the 4 quarters shown below, every one of them. Figures are as filed with NSE, in ₹ crore.

Quarterly results filed with NSE (₹ crore, EPS in ₹)
Quarter endedTotal incomeProfit before taxNet profitEPSStatus
June 202610.500.791.510.00Un-Audited
March 202618.920.991.220.43Audited
December 202515.700.820.850.92Un-Audited
September 202517.430.370.400.43Un-Audited

Vineet Laboratories Limited shareholding pattern

At the end of September 2026, promoters and the promoter group held 5.98% of Vineet Laboratories Limited, with the public holding 94.02%. That is down 29.87 percentage points from 35.85% in March 2025.

A promoter stake below 25% is low by Indian standards. It can mean ownership is widely spread, or that the founders have sold down over time, so it is worth reading the annual report to see who controls the company.

A falling promoter stake is one of the things investors watch most closely in small companies, because it can signal insiders selling. The quarterly shareholding filings on NSE show who bought or sold.

Shareholding by category, as filed with NSE each quarter
Quarter endedPromoter & Promoter Group (%)Public (%)
September 20265.9894.02
June 20265.9894.02
March 20265.9894.02
February 20265.9894.02
December 202512.4687.54
September 202515.8984.11
June 202529.2670.74
March 202535.8564.15

Vineet Laboratories Limited share price performance

Over the past year the Vineet Laboratories Limited share price has lost 5.57%, against a fall of 10.92% for the NIFTY 50, so it has outperformed that index by 5.35 percentage points.

Across the 7 periods in the table, the stock beat the NIFTY 50 in 4. Past returns describe what happened; they do not predict what comes next.

Price change by period, as of 2026-11-02 (NSE)
PeriodVINEETLABNIFTY 50
1 month+2.23%+1.91%
3 months-2.24%-5.20%
6 months-0.18%-3.94%
1 year-5.57%-10.92%
2 years-19.00%-5.29%
3 years-13.30%+20.44%
5 years-43.21%+30.45%

Vineet Laboratories Limited vs industry peers

NSE compares Vineet Laboratories Limited with 6 other listed companies in Pharmaceuticals. By market capitalisation it ranks 4 of 7.

Its P/E of 18.28 compares with a median of 24.21 for the other companies in the group.

NSE industry peer comparison, results for JUN 2026 quarter (₹ crore)
CompanyMarket capPrice (₹)P/EPromoter %Qtr incomeQtr net profit
ALPA10750.8024.2157.1929.761.04
VAISHALI87.616.4919.5631.6123.471.49
VILINBIO79.3852.0541.1556.65——
VINEETLAB72.9637.9918.285.9810.501.51
ONYX65.2836.00—0.00——
JFLLIFE64.679.8026.3567.4711.121.11
ZENITHDRUG63.4537.0016.090.00——

Vineet Laboratories Limited announcements, board meetings and corporate actions

Latest announcements

The most recent filings Vineet Laboratories Limited has made with NSE, newest first:

  • 30-Oct-2026 · Copy of Newspaper Publication: Vineet Laboratories Limited has informed the Exchange about Copy of Newspaper Publication (PDF)
  • 26-Oct-2026 · Statement of deviation(s) or variation(s) under Reg. 32: Vineet Laboratories Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32 (PDF)
  • 26-Oct-2026 · Outcome of Board Meeting: Vineet Laboratories Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026. (PDF)
  • 19-Oct-2026 · Certificate under SEBI (Depositories and Participants) Regulations, 2018: Vineet Laboratories Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 (PDF)
  • 15-Oct-2026 · Resignation of Director/KMP/SMP: Vineet Laboratories Limited has informed the Exchange about Resignation of Director/KMP/SMP (PDF)
  • 14-Oct-2026 · Appointment: Vineet Laboratories Limited has informed the Exchange regarding Appointment of Avula Navaneeswara Reddy as Non- Executive Director of the company w.e.f. October 14, 2026. (PDF)
  • 14-Oct-2026 · Resignation: Vineet Laboratories Limited has informed the Exchange regarding Resignation of Vennapusa Premanand Reddy as Non- Executive Director of the company w.e.f. October 14, 2026. (PDF)
  • 08-Oct-2026 · General Updates: Vineet Laboratories Limited has informed the Exchange about General Updates Clarification Regarding Clerical/Typographical Error In The Cash Flow Statement Of The Audited Financial Results For The Quarter And Year Ended March 31, 2026. (PDF)

Board meetings

  • 04-Nov-2026 · Other business matters: To consider other business matters
  • 26-Oct-2026 · Financial Results/Other business matters: To consider and approve the financial results for the period ended Jun 30, 2026 and other business matters
  • 30-May-2026 · Financial Results: To consider and approve the financial results for the period ended March 31, 2026
  • 14-Feb-2026 · Financial Results: To consider and approve the financial results for the period ended December 31, 2025 along with the limited review report.
  • 27-Nov-2025 · Fund Raising: To consider and approve the proposal of Fund Raising by way of issue of equity shares through Rights Issue.

Corporate actions

The corporate actions on record include 1 dividend, 1 rights issue. The ex-date is the first day the shares trade without the entitlement.

  • Rights 13:12 @ Premium Rs 20/- · ex-date 23-Dec-2025 · record date 23-Dec-2025
  • Annual General Meeting · ex-date 17-Sep-2024 · book closure 19-Sep-2024 to 27-Sep-2024
  • Annual General Meeting · ex-date 18-Sep-2023 · book closure 20-Sep-2023 to 28-Sep-2023
  • Dividend - Re 1 Per Share · ex-date 19-Sep-2022 · record date 20-Sep-2022
  • Annual General Meeting · ex-date 22-Sep-2021 · book closure 24-Sep-2021 to 30-Sep-2021

Risk notice: low-priced and small-company shares can be illiquid, volatile and subject to manipulation, and shareholders can lose their entire investment. This page is a factual summary, not a recommendation to buy or sell Vineet Laboratories Limited.

Where to find Vineet Laboratories Limited's financials

Direct downloads from NSE:

For full financial statements, shareholding detail and every company announcement, go to the source:

Other Pharmaceuticals stocks on MCX Trends

Frequently asked questions

What is the Vineet Laboratories Limited share price?

Vineet Laboratories Limited (NSE: VINEETLAB) closed at ₹37.52 in the end-of-day data for 16 November 2026. For a live price, use the NSE quote page or your broker, because this page is updated from end-of-day files.

Which sector does Vineet Laboratories Limited belong to?

NSE classifies Vineet Laboratories Limited under Pharmaceuticals, in the Healthcare sector.

What is the 52-week high and low of VINEETLAB?

The 52-week high is ₹43.50 (27-APR-2026) and the 52-week low is ₹27.96 (09-MAR-2026), according to NSE.

Is Vineet Laboratories Limited a penny stock?

At ₹37.52 the share trades below ₹50, so it appears on our list of penny stocks under ₹50. A low share price on its own says nothing about whether a company is cheap or expensive; market capitalisation, debt, profits and exchange surveillance status matter far more.

What is the promoter holding in Vineet Laboratories Limited?

Promoters and the promoter group held 5.98% of Vineet Laboratories Limited at the end of September 2026, according to the shareholding pattern filed with NSE.

What were Vineet Laboratories Limited's latest quarterly results?

For the quarter ended June 2026, Vineet Laboratories Limited reported total income of ₹10.50 crore and a net profit of ₹1.51 crore (EPS ₹0.00).

Where can I find Vineet Laboratories Limited's annual report and financial results?

Annual reports, quarterly results and other filings are published on the NSE corporate filings pages (search for VINEETLAB) and on BSE. Screener also lays out several years of financial statements in one place. Links to all of these are above.

More on MCX Trends